Global Gabapentin Market Growth 2020-2025

Tables and Figures

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Gabapentin Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Capsule
Table 5. Major Players of Tablet
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Gabapentin Consumption Market Share by Type (2015-2020)
Table 8. Global Gabapentin Revenue by Type (2015-2020) ($ million)
Table 9. Global Gabapentin Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Gabapentin Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Gabapentin Consumption Market Share by Application (2015-2020)
Table 13. Global Gabapentin Value by Application (2015-2020)
Table 14. Global Gabapentin Value Market Share by Application (2015-2020)
Table 15. Global Gabapentin Sale Price by Application (2015-2020)
Table 16. Global Gabapentin Sales by Company (2017-2019) (K MT)
Table 17. Global Gabapentin Sales Market Share by Company (2017-2019)
Table 18. Global Gabapentin Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Gabapentin Revenue Market Share by Company (2017-2019)
Table 20. Global Gabapentin Sale Price by Company (2017-2019)
Table 21. Global Gabapentin Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Gabapentin Products Offered
Table 23. Gabapentin Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Gabapentin Consumption by Regions 2015-2020 (K MT)
Table 25. Global Gabapentin Consumption Market Share by Regions 2015-2020
Table 26. Global Gabapentin Value by Regions 2015-2020 ($ Millions)
Table 27. Global Gabapentin Value Market Share by Regions 2015-2020
Table 28. Americas Gabapentin Consumption by Countries (2015-2020) (K MT)
Table 29. Americas Gabapentin Consumption Market Share by Countries (2015-2020)
Table 30. Americas Gabapentin Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Gabapentin Value Market Share by Countries (2015-2020)
Table 32. Americas Gabapentin Consumption by Type (2015-2020) (K MT)
Table 33. Americas Gabapentin Consumption Market Share by Type (2015-2020)
Table 34. Americas Gabapentin Consumption by Application (2015-2020) (K MT)
Table 35. Americas Gabapentin Consumption Market Share by Application (2015-2020)
Table 36. APAC Gabapentin Consumption by Countries (2015-2020) (K MT)
Table 37. APAC Gabapentin Consumption Market Share by Countries (2015-2020)
Table 38. APAC Gabapentin Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Gabapentin Value Market Share by Regions (2015-2020)
Table 40. APAC Gabapentin Consumption by Type (2015-2020) (K MT)
Table 41. APAC Gabapentin Consumption Market Share by Type (2015-2020)
Table 42. APAC Gabapentin Consumption by Application (2015-2020) (K MT)
Table 43. APAC Gabapentin Consumption Market Share by Application (2015-2020)
Table 44. Europe Gabapentin Consumption by Countries (2015-2020) (K MT)
Table 45. Europe Gabapentin Consumption Market Share by Countries (2015-2020)
Table 46. Europe Gabapentin Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Gabapentin Value Market Share by Countries (2015-2020)
Table 48. Europe Gabapentin Consumption by Type (2015-2020) (K MT)
Table 49. Europe Gabapentin Consumption Market Share by Type (2015-2020)
Table 50. Europe Gabapentin Consumption by Application (2015-2020) (K MT)
Table 51. Europe Gabapentin Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Gabapentin Consumption by Countries (2015-2020) (K MT)
Table 53. Middle East & Africa Gabapentin Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Gabapentin Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Gabapentin Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Gabapentin Consumption by Type (2015-2020) (K MT)
Table 57. Middle East & Africa Gabapentin Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Gabapentin Consumption by Application (2015-2020) (K MT)
Table 59. Middle East & Africa Gabapentin Consumption Market Share by Application (2015-2020)
Table 60. Gabapentin Distributors List
Table 61. Gabapentin Customer List
Table 62. Global Gabapentin Consumption Forecast by Countries (2021-2025) (K MT)
Table 63. Global Gabapentin Consumption Market Forecast by Regions
Table 64. Global Gabapentin Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Gabapentin Value Market Share Forecast by Regions
Table 66. Global Gabapentin Consumption Forecast by Type (2021-2025) (K MT)
Table 67. Global Gabapentin Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Gabapentin Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Gabapentin Value Market Share Forecast by Type (2021-2025)
Table 70. Global Gabapentin Consumption Forecast by Application (2021-2025) (K MT)
Table 71. Global Gabapentin Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Gabapentin Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Gabapentin Value Market Share Forecast by Application (2021-2025)
Table 74. Pfizer Product Offered
Table 75. Pfizer Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Pfizer Basic Information, Company Total Revenue (in $ million), Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 79. Intas Product Offered
Table 80. Intas Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 81. Intas Main Business
Table 82. Intas Latest Developments
Table 83. Intas Basic Information, Company Total Revenue (in $ million), Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 84. Assertio Therapeutics Product Offered
Table 85. Assertio Therapeutics Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 86. Assertio Therapeutics Main Business
Table 87. Assertio Therapeutics Latest Developments
Table 88. Assertio Therapeutics Basic Information, Company Total Revenue (in $ million), Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 89. Mylan Product Offered
Table 90. Mylan Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 91. Mylan Main Business
Table 92. Mylan Latest Developments
Table 93. Mylan Basic Information, Company Total Revenue (in $ million), Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 94. Arbor Pharma Product Offered
Table 95. Arbor Pharma Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 96. Arbor Pharma Main Business
Table 97. Arbor Pharma Latest Developments
Table 98. Arbor Pharma Basic Information, Company Total Revenue (in $ million), Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 99. TEVA Product Offered
Table 100. TEVA Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 101. TEVA Main Business
Table 102. TEVA Latest Developments
Table 103. TEVA Basic Information, Company Total Revenue (in $ million), Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 104. Sun Pharmaceutical Product Offered
Table 105. Sun Pharmaceutical Basic Information, Company Total Revenue (in $ million), Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 106. Sun Pharmaceutical Main Business
Table 107. Sun Pharmaceutical Latest Developments
Table 108. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 109. Novartis Product Offered
Table 110. Novartis Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 111. Novartis Main Business
Table 112. Novartis Latest Developments
Table 113. Novartis Basic Information, Company Total Revenue (in $ million), Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 114. Aurobindo Pharma Product Offered
Table 115. Aurobindo Pharma Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 116. Aurobindo Pharma Main Business
Table 117. Aurobindo Pharma Latest Developments
Table 118. Aurobindo Pharma Basic Information, Company Total Revenue (in $ million), Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 119. Apotex Product Offered
Table 120. Apotex Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 121. Apotex Main Business
Table 122. Apotex Latest Developments
Table 123. Apotex Basic Information, Company Total Revenue (in $ million), Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu Hengrui Product Offered
Table 125. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 126. Jiangsu Hengrui Main Business
Table 127. Jiangsu Hengrui Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Hengrui Latest Developments
Table 129. Sailike Product Offered
Table 130. Sailike Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 131. Sailike Main Business
Table 132. Sailike Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Sailike Latest Developments
Table 134. Amneal Product Offered
Table 135. Amneal Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 136. Amneal Main Business
Table 137. Amneal Latest Developments
Table 138. Amneal Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Alkem Product Offered
Table 140. Alkem Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 141. Alkem Main Business
Table 142. Alkem Latest Developments
Table 143. Alkem Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Glenmark Product Offered
Table 145. Glenmark Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 146. Glenmark Main Business
Table 147. Glenmark Latest Developments
Table 148. Glenmark Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Jiangsu Enhua Product Offered
Table 150. Jiangsu Enhua Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 151. Jiangsu Enhua Main Business
Table 152. Jiangsu Enhua Latest Developments
Table 153. Jiangsu Enhua Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Marksans Pharma Product Offered
Table 155. Marksans Pharma Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 156. Marksans Pharma Main Business
Table 157. Marksans Pharma Latest Developments
Table 158. Marksans Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Gabapentin
Figure 2. Gabapentin Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Gabapentin Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Gabapentin Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Capsule
Figure 7. Product Picture of Tablet
Figure 8. Global Gabapentin Consumption Market Share by Type (2015-2020)
Figure 9. Global Gabapentin Value Market Share by Type (2015-2020)
Figure 10. Gabapentin Consumed in Epilepsy
Figure 11. Global Gabapentin Market: Epilepsy (2015-2020) (K MT)
Figure 12. Global Gabapentin Market: Epilepsy (2015-2020) ($ Millions)
Figure 13. Gabapentin Consumed in Neuropathic Pain
Figure 14. Global Gabapentin Market: Neuropathic Pain (2015-2020) (K MT)
Figure 15. Global Gabapentin Market: Neuropathic Pain (2015-2020) ($ Millions)
Figure 16. Gabapentin Consumed in Restless Legs Syndrome
Figure 17. Global Gabapentin Market: Restless Legs Syndrome (2015-2020) (K MT)
Figure 18. Global Gabapentin Market: Restless Legs Syndrome (2015-2020) ($ Millions)
Figure 19. Gabapentin Consumed in Others
Figure 20. Global Gabapentin Market: Others (2015-2020) (K MT)
Figure 21. Global Gabapentin Market: Others (2015-2020) ($ Millions)
Figure 22. Global Gabapentin Consumption Market Share by Application (2015-2020)
Figure 23. Global Gabapentin Value Market Share by Application (2015-2020)
Figure 24. Global Gabapentin Sales Market Share by Company in 2017
Figure 25. Global Gabapentin Sales Market Share by Company in 2019
Figure 26. Global Gabapentin Revenue Market Share by Company in 2017
Figure 27. Global Gabapentin Revenue Market Share by Company in 2019
Figure 28. Global Gabapentin Sale Price by Company in 2019
Figure 29. Global Gabapentin Consumption Market Share by Regions 2015-2020
Figure 30. Global Gabapentin Value Market Share by Regions 2015-2020
Figure 31. Americas Gabapentin Consumption 2015-2020 (K MT)
Figure 32. Americas Gabapentin Value 2015-2020 ($ Millions)
Figure 33. APAC Gabapentin Consumption 2015-2020 (K MT)
Figure 34. APAC Gabapentin Value 2015-2020 ($ Millions)
Figure 35. Europe Gabapentin Consumption 2015-2020 (K MT)
Figure 36. Europe Gabapentin Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Gabapentin Consumption 2015-2020 (K MT)
Figure 38. Middle East & Africa Gabapentin Value 2015-2020 ($ Millions)
Figure 39. Americas Gabapentin Consumption Market Share by Countries in 2019
Figure 40. Americas Gabapentin Value Market Share by Countries in 2019
Figure 41. Americas Gabapentin Consumption Market Share by Type in 2019
Figure 42. Americas Gabapentin Consumption Market Share by Application in 2019
Figure 43. United States Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 44. United States Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 46. Canada Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 48. Mexico Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Gabapentin Consumption Market Share by Countries in 2019
Figure 50. APAC Gabapentin Value Market Share by Regions in 2019
Figure 51. APAC Gabapentin Consumption Market Share by Type in 2019
Figure 52. APAC Gabapentin Consumption Market Share by Application in 2019
Figure 53. China Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 54. China Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 56. Japan Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 58. Korea Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 60. Southeast Asia Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 61. India Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 62. India Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 64. Australia Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Gabapentin Consumption Market Share by Countries in 2019
Figure 66. Europe Gabapentin Value Market Share by Countries in 2019
Figure 67. Europe Gabapentin Consumption Market Share by Type in 2019
Figure 68. Europe Gabapentin Consumption Market Share by Application in 2019
Figure 69. Germany Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 70. Germany Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 71. France Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 72. France Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 73. UK Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 74. UK Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 76. Italy Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 78. Russia Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Gabapentin Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Gabapentin Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Gabapentin Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Gabapentin Consumption Market Share by Application in 2019
Figure 83. Egypt Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 84. Egypt Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 86. South Africa Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 88. Israel Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 90. Turkey Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Gabapentin Consumption Growth 2015-2020 (K MT)
Figure 92. GCC Countries Gabapentin Value Growth 2015-2020 ($ Millions)
Figure 93. Global Gabapentin Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 94. Global Gabapentin Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Gabapentin Consumption 2021-2025 (K MT)
Figure 96. Americas Gabapentin Value 2021-2025 ($ Millions)
Figure 97. APAC Gabapentin Consumption 2021-2025 (K MT)
Figure 98. APAC Gabapentin Value 2021-2025 ($ Millions)
Figure 99. Europe Gabapentin Consumption 2021-2025 (K MT)
Figure 100. Europe Gabapentin Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Gabapentin Consumption 2021-2025 (K MT)
Figure 102. Middle East & Africa Gabapentin Value 2021-2025 ($ Millions)
Figure 103. United States Gabapentin Consumption 2021-2025 (K MT)
Figure 104. United States Gabapentin Value 2021-2025 ($ Millions)
Figure 105. Canada Gabapentin Consumption 2021-2025 (K MT)
Figure 106. Canada Gabapentin Value 2021-2025 ($ Millions)
Figure 107. Mexico Gabapentin Consumption 2021-2025 (K MT)
Figure 108. Mexico Gabapentin Value 2021-2025 ($ Millions)
Figure 109. Brazil Gabapentin Consumption 2021-2025 (K MT)
Figure 110. Brazil Gabapentin Value 2021-2025 ($ Millions)
Figure 111. China Gabapentin Consumption 2021-2025 (K MT)
Figure 112. China Gabapentin Value 2021-2025 ($ Millions)
Figure 113. Japan Gabapentin Consumption 2021-2025 (K MT)
Figure 114. Japan Gabapentin Value 2021-2025 ($ Millions)
Figure 115. Korea Gabapentin Consumption 2021-2025 (K MT)
Figure 116. Korea Gabapentin Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Gabapentin Consumption 2021-2025 (K MT)
Figure 118. Southeast Asia Gabapentin Value 2021-2025 ($ Millions)
Figure 119. India Gabapentin Consumption 2021-2025 (K MT)
Figure 120. India Gabapentin Value 2021-2025 ($ Millions)
Figure 121. Australia Gabapentin Consumption 2021-2025 (K MT)
Figure 122. Australia Gabapentin Value 2021-2025 ($ Millions)
Figure 123. Germany Gabapentin Consumption 2021-2025 (K MT)
Figure 124. Germany Gabapentin Value 2021-2025 ($ Millions)
Figure 125. France Gabapentin Consumption 2021-2025 (K MT)
Figure 126. France Gabapentin Value 2021-2025 ($ Millions)
Figure 127. UK Gabapentin Consumption 2021-2025 (K MT)
Figure 128. UK Gabapentin Value 2021-2025 ($ Millions)
Figure 129. Italy Gabapentin Consumption 2021-2025 (K MT)
Figure 130. Italy Gabapentin Value 2021-2025 ($ Millions)
Figure 131. Russia Gabapentin Consumption 2021-2025 (K MT)
Figure 132. Russia Gabapentin Value 2021-2025 ($ Millions)
Figure 133. Spain Gabapentin Consumption 2021-2025 (K MT)
Figure 134. Spain Gabapentin Value 2021-2025 ($ Millions)
Figure 135. Egypt Gabapentin Consumption 2021-2025 (K MT)
Figure 136. Egypt Gabapentin Value 2021-2025 ($ Millions)
Figure 137. South Africa Gabapentin Consumption 2021-2025 (K MT)
Figure 138. South Africa Gabapentin Value 2021-2025 ($ Millions)
Figure 139. Israel Gabapentin Consumption 2021-2025 (K MT)
Figure 140. Israel Gabapentin Value 2021-2025 ($ Millions)
Figure 141. Turkey Gabapentin Consumption 2021-2025 (K MT)
Figure 142. Turkey Gabapentin Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Gabapentin Consumption 2021-2025 (K MT)
Figure 144. GCC Countries Gabapentin Value 2021-2025 ($ Millions)
Figure 145. Pfizer Gabapentin Market Share (2018-2020)
Figure 146. Intas Gabapentin Market Share (2018-2020)
Figure 147. Assertio Therapeutics Gabapentin Market Share (2018-2020)
Figure 148. Mylan Gabapentin Market Share (2018-2020)
Figure 149. Arbor Pharma Gabapentin Market Share (2018-2020)
Figure 150. TEVA Gabapentin Market Share (2018-2020)
Figure 151. Sun Pharmaceutical Gabapentin Market Share (2018-2020)
Figure 152. Novartis Gabapentin Market Share (2018-2020)
Figure 153. Aurobindo Pharma Gabapentin Market Share (2018-2020)
Figure 154. Apotex Gabapentin Market Share (2018-2020)
Figure 155. Jiangsu Hengrui Gabapentin Market Share (2018-2020)
Figure 156. Sailike Gabapentin Market Share (2018-2020)
Figure 157. Amneal Gabapentin Market Share (2018-2020)
Figure 158. Alkem Gabapentin Market Share (2018-2020)
Figure 159. Glenmark Gabapentin Market Share (2018-2020)
Figure 160. Jiangsu Enhua Gabapentin Market Share (2018-2020)
Figure 161. Marksans Pharma Gabapentin Market Share (2018-2020)

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets